Literature DB >> 6276465

A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis.

N W Preston, N Surapatana, E J Carter.   

Abstract

Twelve strains of Bordetella pertussis, of various serotypes, were tested by agglutination with serial dilutions of six antisera which were thought by their donor to be monospecific for six distinct agglutinogens. The first three sera were shown, by agglutination of the twelve donated strains and of standard pertussis serotypes, to be monospecific for the three well-recognized major agglutinogens (factor 1, factor 2, factor 3). The 'factor 4' serum gave weak agglutination, but only of strains that possessed factor 2, though not all of such strains. This suggested that it may be a distinct minor component of factor 2. The 'factor 5' serum was very weak, and gave agglutination only with a few of the factor 2 strains. The titres of the 'factor 6' serum were very closely parallel to those of the factor 3 serum, and it may be inferred that these 'factors' probably constitute a single antigenic entity. Seven of the twelve donated strains were shown to be mixtures of two or more serotypes, offering an explanation for discrepancies in serological tests involving the use of these strains on different occasions. It seems likely that 'factors 5 and 6' do not actually exist; and, since 'factor 4' is only a minor component of factor 2, any protective role that it may have would probably be covered by the presence of factor 2 in vaccine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6276465      PMCID: PMC2134147          DOI: 10.1017/s0022172400069874

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  12 in total

1.  Bordetella pertussis serotypes in Canada.

Authors:  S Toma; H Lo; M Magus
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

2.  The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period.

Authors:  C Bronne-Shanbury; D Miller; A F Standfast
Journal:  J Hyg (Lond)       Date:  1976-04

3.  Serological studies on H. pertussis H. parapertussis and H. bronchisepticus.

Authors:  E K ANDERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1953

4.  Prevalent serotypes of Bordetella pertussis in non-vaccinated communities.

Authors:  N W Preston
Journal:  J Hyg (Lond)       Date:  1976-08

5.  Variation of serotype in strains of Bordetella pertussis.

Authors:  T N Stanbridge; N W Preston
Journal:  J Hyg (Lond)       Date:  1974-10

Review 6.  Some unsolved problems with vaccines.

Authors:  N W Preston
Journal:  Prog Drug Res       Date:  1979

7.  Technical problems in the laboratory diagnosis and prevention of whooping-cough.

Authors:  N W Preston
Journal:  Lab Pract       Date:  1970-05

8.  Experimental pertussis infection in the rabbit: similarities with infection in primates.

Authors:  N W Preston; R M Timewell; E J Carter
Journal:  J Infect       Date:  1980-09       Impact factor: 6.072

9.  Potency tests for pertussis vaccines: doubtful value of intracerebral challenge test in mice.

Authors:  N W Preston
Journal:  J Pathol Bacteriol       Date:  1966-01

10.  Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection.

Authors:  J M Dolby; S Stephens
Journal:  J Hyg (Lond)       Date:  1973-03
View more
  7 in total

1.  Assessing the response to pertussis vaccine.

Authors:  N W Preston
Journal:  BMJ       Date:  1991-11-09

Review 2.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

3.  Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes.

Authors:  A A Weiss; A R Melton; K E Walker; C Andraos-Selim; J J Meidl
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.

Authors:  Z M Li; M J Brennan; J L David; P H Carter; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

5.  Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.

Authors:  M J Brennan; Z M Li; J L Cowell; M E Bisher; A C Steven; P Novotny; C R Manclark
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

6.  Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.

Authors:  J L Cowell; J M Zhang; A Urisu; A Suzuki; A C Steven; T Liu; T Y Liu; C R Manclark
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

7.  Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features.

Authors:  M Caroff; R Chaby; D Karibian; J Perry; C Deprun; L Szabó
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.